ITC Staff Sides With Merck In NuvaRing Patent Battle
The investigative staff of the U.S. International Trade Commission recommended in a prehearing brief made public Tuesday that evidence would likely show Merck & Co. Inc. did not violate a Femina...To view the full article, register now.
Already a subscriber? Click here to view full article